Ysk Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.10 Cr
- Paid Up Capital ₹ 2.01 Cr
- Company Age 1 Year 10 Months
- Open Charges ₹ 3.50 Cr
About Ysk Laboratories
Ysk Laboratories Private Limited (YLPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 April 2023 (One year and ten months 5 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 2.10 Cr and a paid-up capital of Rs 2.01 Cr.
The company currently has active open charges totaling ₹3.50 Cr.
Jitesh Rameshchandra, Abhijit Gothoskar, Yuvansh Khokhani, and One other member serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U20299MH2023PTC400166
-
Company No.
400166
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Apr 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Ysk Laboratories?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitesh Rameshchandra
|
Director | 01-Nov-2023 | Current |
|
Abhijit Gothoskar
|
Director | 05-Apr-2023 | Current |
|
Yuvansh Khokhani
|
Director | 05-Apr-2023 | Current |
|
Rajesh Mulik
|
Director | 16-Nov-2023 | Current |
Financial Performance of Ysk Laboratories.
Enhance accessibility to Ysk Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ysk Laboratories?
Unlock access to Ysk Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Citron Life Sciences Private LimitedAbhijit Gothoskar is a mutual person
-
Unimark Remedies LimitedJitesh Rameshchandra is a mutual person
-
Raajshi Invecorp LlpJitesh Rameshchandra is a mutual person
-
Shamrock Steriotech Llp
Jitesh Rameshchandra is a mutual person
-
Shiraj Invecorp Llp
Jitesh Rameshchandra is a mutual person
-
Shamrock Pharma Llp
Jitesh Rameshchandra is a mutual person
Charges (Loans)
₹3.50 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 3.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Sep 2023 | State Bank Of India | ₹3.50 Cr | Open |
How Many Employees Work at Ysk Laboratories?
Unlock and access historical data on people associated with Ysk Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ysk Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ysk Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
